Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
2 of 6 columns
Comparison
| Attribute | Conexeu Sciences Inc.22.1remove | OS Therapies Inc10.6remove |
|---|---|---|
| Signal scores | ||
| Radar composite | 22.1 | 10.6 |
| IPO signal score | 44.1 | 21.2 |
| Tokenization signal score | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 |
| Momentum | ACCELERATING+23.8 | ACCELERATING+11.2 |
| Company | ||
| Stage | public | private |
| Sector | Technology | Technology |
| Headquarters | RENO, United States | Grasonville, United States |
| Founded | 2022 | not on record |
| Employees | not on record | not on record |
| Capital | ||
| Latest valuation | not on record | not on record |
| Total funding | $151K | $5M |
| Latest round | Private Placement $89K | Private Placement $5M |
| Investors on record | 0 | 0 |
| Evidence | ||
| Institutional relationships | 0 | 0 |
| Active signals | 30 | 36 |
| Confidence | 80% | 68% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.